Clinical Investigation to Evaluate the Effectiveness and Safety of ECG App
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 673 participants.
Also called NCT05482503
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; single masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 673 participants
- Sponsor
- Huawei Device Co., Ltd
- Registry
-
NCT05482503
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT05482503. Non-randomized; single masking; primary purpose diagnostic. Start 2021-04-02 (actual); primary completion 2021-09-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Investigation to Evaluate the Effectiveness and Safety of ECG App
- Condition
- Arrhythmias, Cardiac
- Intervention (Device)
- 12-Lead ECG (electrocardiogram)(I-lead)
- Lead sponsor
- Huawei Device Co., Ltd
Record details
- Record id
cardio:ct-nct05482503- Content hash
3e736117695dc6610abec7545cb3f1eaff867647a7a1c13633f12ba8e23599dd